Mass spectrometric analyses of proteoglycans - Novel tools for studying prohormones in insulin-producing cells
Abstract
Proteoglycans (PGs) are proteins that carry one or more negatively charged
glycosaminoglycan (GAG) chains. Proteoglycans have been identified in
essentially all multicellular organisms, and are implicated in a wide range of
biological and pathological processes. To further decipher the influence of
GAG glycosylation on biological and pathological events in humans, detailed
structural characterization of PGs/GAGs is needed. However, studying the
PGs/GAGs is very challenging and has been hampered by the limited number
of analytical tools available.
In this thesis work, we have developed and applied glycoproteomics and
glycomics methods to characterize PGs and their GAG structures and
investigated their possible influence on the cellular characteristics of insulin-producing cells. The workflow included isolation, enrichment, and enzymatic
depolymerization of PG/GAG structures followed by structural analysis using
liquid chromatography-tandem mass spectrometry. We identified several
different chondroitin/dermatan sulfate (CS/DS) and heparan sulfate (HS) PGs,
some of which are novel PGs. Several of the identified PGs, such as
chromogranin-A (CgA) belong to the granin family of secretory granules
which are typically co-stored, co-processed and co-released with the insulin
hormone. Considering that several of the PGs identified belong to the granin
family, and that the granins are important for the biogenesis of dense-core
secretory granules, we started to explore the cellular effects of blocking the
GAG glycosylation in rat INS-1 832/13 cells by using the CRISPR/Cas9
technique. Our data showed that B4galt7-KO clones had a major, but not
always complete, block of the GAG glycosylation of the CgA protein.
Furthermore, the cellular localization of CgA as well as its proteolytic
processing was different in KO cells compared to WT cells. Further studies of
the effects of downregulation of the GAG biosynthesis in these clones are
ongoing.
In summary, our structural findings may assist in elucidating the influence of
GAG modifications on the storage, processing, and secretion of peptide
hormones of endocrine cells, with particular relevance to insulin-secreting beta
cells. Given the paramount importance of insulin on glucose homeostasis,
these novel aspects of GAG glycosylation presented herein may provide new
insights into diabetes research and future treatment strategies.
Parts of work
I. A glycoproteomic approach to identify novel proteoglycans. Noborn F, Nikpour M, Persson A, Sihlbom C, Nilsson J, and Larson G. Accepted for publication in Methods in Molecular Biology, Special volume on Glycosaminoglycans: Chemistry & Biology, 2020. ::DOI::10.1007/978-1-0716-1397-9_7 II. Proteoglycan profiling of human, rat and mouse insulin-secreting cells. Nikpour M, Nilsson J, Persson A, Noborn F, Vorontsov E, and Larson G. Manuscript III. Structural domain mapping of proteoglycan-derived glycosaminoglycans from rat insulinoma cells. Persson A, Nikpour M, Vorontsov E, Nilsson J, and Larson G. Manuscript IV. Establishing B4galt7 knock-down clones of the rat INS-1 832/13 insulinoma cell line for studying biological effects of downregulation of GAG biosynthesis. Nikpour M, Madsen TD, Satir DM, Gomez Toledo A, Nilsson A, Persson A, Noborn F, Schjoldager KT, and Larson G. Manuscript
Degree
Doctor of Philosophy (Medicine)
University
University of Gothenburg. Sahlgrenska Academy
Institution
Institute of Biomedicine. Department of Laboratory Medicine
Disputation
Fredagen den 18 december 2020, kl. 13.00, Hörsal Europa, Wallenberg Conference Center, medicinaregatan 20
Date of defence
2020-12-18
mahnaz.nikpour@gu.se
Date
2020-12-15Author
Nikpour, Mahnaz
Keywords
proteoglycan
glycosaminoglycan
mass spectrometry
secretory granule
prohormones
CRISPR/Cas9
Publication type
Doctoral thesis
ISBN
978-91-8009-124-4 (Print)
978-91-8009-125-1 (PDF)
Language
eng